NAYA Biosciences News

NAYA Biosciences | EFFECT: Others

Dec 23, 2024 06:06 ET

NAYA Biosciences | S-1: General form for registration of securities under the Securities Act of 1933

Dec 17, 2024 15:58 ET

NAYA Biosciences | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Dec 13, 2024 17:31 ET

NAYA Biosciences | 8-K/A: Current report (Amendment)

Dec 12, 2024 16:51 ET

NAYA Biosciences | 10-Q: Q3 2024 Earnings Report

Nov 19, 2024 16:22 ET

NAYA Biosciences | 10-Q/A: Quarterly report (Amendment)

Nov 19, 2024 16:17 ET

NAYA Biosciences | 10-K/A: Annual report (Amendment)

Nov 19, 2024 16:13 ET

NAYA Biosciences | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Nov 14, 2024 16:58 ET

NAYA Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.5%),Daniel B. Asher(4.5%), etc.

Nov 13, 2024 11:22 ET

NAYA Biosciences | 8-K: Current report

Nov 8, 2024 16:21 ET

RW: Registration Withdrawal Request

Oct 22, 2024 12:08 ET

INVO Bioscience | 8-K: Current report

Oct 15, 2024 09:19 ET

INVO Bioscience | 8-K: Current report

Oct 1, 2024 17:31 ET

INVO Bioscience | 8-K: Current report

Sep 20, 2024 16:08 ET

INVO Bioscience | 8-K: Current report

Sep 18, 2024 17:22 ET

INVO Bioscience | 8-K: INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA

Aug 14, 2024 16:14 ET

INVO Bioscience | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 09:05 ET

INVO Bioscience | 8-K: Current report

Jul 5, 2024 16:08 ET

INVO Bioscience | 8-K: Current report

Jun 20, 2024 16:23 ET

INVO Bioscience | S-3: Registration statement for specified transactions by certain issuers

May 21, 2024 16:41 ET